Alpha Omega

Company Overview

Snapshot

Founded in April 1993 by Imad Younis and Reem Younis, Alpha Omega operates with over 500 employees. The company has raised $7 million across one funding round from Guangzhou Sino-Israel Biotech Investment Fund (GIBF). In August 2024, the company was noted for expanding its operations to Jenin, demonstrating a strategic move to broaden its reach.

Business overview

Alpha Omega is a medical device company specializing in neurosurgery and neuroscience, providing solutions to enhance and simplify deep brain stimulation (DBS) therapy and procedures. The company develops sophisticated software and hardware for brain mapping and navigation, applicable for both sleeping and awake procedures, aiming to increase treatment productivity for neurological and psychiatric disorders. Alpha Omega serves the healthcare and life sciences sectors, specifically targeting hospitals, laboratories, and academic researchers with its medical equipment, monitoring, and diagnostic devices.

Strategic signal

In August 2024, Alpha Omega expanded its operations to Jenin, a strategic move highlighted in the Times of Israel. This expansion signals the company's commitment to growth and market penetration, particularly in regions that may offer new opportunities for its medical device solutions in neurosurgery and neuroscience. For investors, this indicates a proactive approach to market development and a potential for increased operational scale.

Company Intelligence Q&A

What is Alpha Omega's primary focus in the medical device industry?

Alpha Omega specializes in functional neurosurgery and neuroscience research solutions, providing advanced medical devices for deep brain stimulation (DBS) therapy and procedures.

Who founded Alpha Omega and when?

Alpha Omega was founded in April 1993 by Imad Younis and Reem Younis.

What was a significant strategic move for Alpha Omega in 2024?

In August 2024, Alpha Omega expanded its operations by taking its medical technology to Jenin, as reported by The Times of Israel.

Has Alpha Omega engaged in any notable partnerships?

In April 2019, Medtronic announced plans to market Alpha Omega's neurosurgery system, indicating a significant partnership for market reach.